Remove category supply-chain-logistics
article thumbnail

Pharmapack Awards 2024 entries open

European Pharmaceutical Review

Two new categories and eight prizes in total are divided into two separate streams: Exhibitor Innovation Awards and the Health Product Awards. The Exhibitor Innovation Awards celebrate ‘new concepts in packaging materials, including primary or secondary packaging, cool chain and logistics, start-ups, and drug delivery solutions’.

article thumbnail

How Supply Chain Planning Can Help Pharma Meet All-Time High Drug Supply Demands

PM360

are in limited supply or unavailable, marking the worst national drug shortage in years. However, companies will be better prepared to survive unexpected setbacks by better managing their supply chain and proactively identifying potential risks. Over 300 drugs in the U.S. Some suggest that the government should incentivize U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Award Shortlists 2022

Pharmaceutical Technology

Business Expansion is one of our largest categories and looks at the core functions of business operations within the sector. The Environmental category aims to highlight companies that are undertaking projects that reduce their impact on the natural environment or contribute to its general health. Business Expansion. Environmental.

article thumbnail

Excellence Awards 2022 – Winners Announced!

Pharmaceutical Technology

Business Expansion is one of our largest categories and looks at the core functions of business operations within the sector. The Environmental category aims to highlight companies that are undertaking projects that reduce their impact on the natural environment or contribute to its general health. Business Expansion. Innovation.

article thumbnail

Untangling the Complexities of Cell and Gene Therapy Clinical Trials: A Supply Chain Perspective 

Pharmaceutical Technology

Every major pharma company is now involved in CGT development which has resulted in the approval of 28 therapies by the FDA thereby making CGT no longer a niche category of therapies. CGT drugs fall into two major categories: autologous and allogeneic. Differences in CGT vs traditional trials supply chain.